| Patient | Mary Seacole |
|---|---|
| Date of birth | 1805-11-23 |
| Identifiers | MRN HR-NI027-SYN-TD; SSN (made up) 000-27-4483 |
| Document date | 1877-04-13 |
| Author | Adwoa Fairweather-Kent, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-week review on two blood pressure medicines. [S]
Mary Seacole returns four weeks after starting amlodipine and chlorthalidone. Her headaches stopped in the second week. Her home readings average 134/80. She has had no dizziness on standing and no ankle swelling. She began physical therapy three weeks ago, does her exercises most days and uses the cane the therapist fitted, in her right hand. The occupational therapist visited and a rail is being fitted on the stairs to her rooms. She has met the social prescribing link worker, who found a tai chi class near her home. Her knees hurt less. She wants to talk about the cholesterol tablet. [S]
| Element | Detail |
|---|---|
| Home readings | Average 134/80 mmHg |
| Headaches | Gone since the second week |
| Side effects | No dizziness or ankle swelling |
| Knees and falls | Physical therapy and a cane; no falls |
| System | Result | Finding |
|---|---|---|
| Neurological | Negative | No headaches, weakness or numbness |
| Cardiovascular | Negative | No dizziness on standing, palpitations or swelling |
| Musculoskeletal | Positive | Knee pain 5 out of 10, better with exercise |
| Genitourinary | Negative | Passing urine a little more in the mornings |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day | 4 g to each knee up to four times a day | Topical route | 1877-03-09 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-03-16 | active | S |
| Chlorthalidone 12.5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1877-03-16 to 1877-05-11 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-04-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1877-04-13 | Body height | 157 | cm | S |
| 1877-04-13 | Body weight | 77.6 | kg | S |
| 1877-04-13 | Body mass index (BMI) [Ratio] | 31.5 | kg/m2 | S |
| 1877-04-13 | Systolic blood pressure | 138 | mm[Hg] | S |
| 1877-04-13 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1877-04-13 | Heart rate | 76 | /min | S |
| 1877-04-13 | Respiratory rate | 16 | /min | S |
| 1877-04-13 | Body temperature | 36.6 | Cel | S |
| 1877-04-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1877-04-13 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 1877-04-13 | Potassium [Moles/volume] in Serum or Plasma | 3.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1877-04-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.95 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1877-04-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1872)/1.73 sq M | 64 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1877-04-13 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1877-04-13 | Left ventricular Ejection fraction | 64 | % | 50-70% | Normal | S |
| 1877-04-13 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S | ||
| 1877-04-13 | Total interval score [KOOSJR] | 56.6 | {score} | S |
Vital signs recorded on 1877-04-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 138/82 seated, 134/80 standing at three minutes, pulse 76; weight 77.6 kg |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Musculoskeletal | No knee effusion; Timed Up and Go 14 seconds with the cane |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmed | resolved | provisional | R03.0 | S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health. |
| Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney disease | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension. |
| Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imaging | active | confirmed | M17.0 | S — Synthetic modern problem; not a claim about her real health. |
| Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk problem. |
| Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her knees | active | confirmed | E66.811 | S — Synthetic modern problem; her self-description as stout is documented, her weight is not. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHg | Every visit | Completed today | 138/82 mmHg; home average 134/80 |
| Examination | Orthostatic blood pressure (lying and standing) | Every visit | Completed today | No orthostatic drop |
| Examination | Weight and BMI (5% weight-loss goal for knee osteoarthritis) | Every visit | Completed today | 77.6 kg, BMI 31.5 |
| Examination | Cardiac auscultation and edema | Every visit | Completed today | No murmur; no edema |
| Laboratory | Sodium, potassium, creatinine and eGFR | Two to four weeks after starting or changing a diuretic or ARB; then every six months on these medicines | Completed today | Four weeks after chlorthalidone: sodium 136, potassium 3.7, creatinine 0.95 mg/dL (eGFR 64), glucose 94 |
| Imaging | Echocardiogram | At diagnosis if stage 2 or left ventricular hypertrophy | Completed today | Ejection fraction 64%; mild concentric left ventricular hypertrophy; grade 1 diastolic dysfunction |
| Laboratory | Lipid panel | Four to twelve weeks after starting a statin, then yearly | Ordered | Atorvastatin 20 mg started today; panel in four to twelve weeks |
| Survey | Knee pain score (0 to 10) | Every visit | Completed today | 5 out of 10 |
| Survey | Knee function (KOOS JR) | Every visit | Completed today | KOOS JR 56.6 |
| Examination | Knee examination (range of motion, effusion, alignment, crepitus) | Every visit | Completed today | No effusion |
| Self-management | Exercise therapy, tai chi and self-management | Ongoing | Completed today | Physical therapy for three weeks; home exercises most days; cane in the right hand |
| Medication safety | NSAID safety (topical diclofenac; no oral NSAIDs) | Every visit | Completed today | Diclofenac gel only |
| Examination | STEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balance | At diagnosis of fall risk, then yearly or with a fall | Completed today | Timed Up and Go 14 seconds |
| Medication safety | Medicine review for fall risk and interactions (Beers criteria) | Every visit | Completed today | Chlorthalidone sodium check done; atorvastatin added |
| Self-management | Home safety, footwear, vision and assistive device | At diagnosis of fall risk, then yearly | Completed today | Occupational therapy visit done; stair rail being fitted; bath board supplied |
| Self-management | Her own remedies: interactions and how she uses them | Every visit | Completed today | Liquorice still paused; liniment on one knee and gel on the other |
| Self-management | Loneliness, costs and transport | Every visit | Completed today | Link worker found a tai chi class; generic medicines in 90-day supplies |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Licorice Root (2026); Ginger (2026); CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026)
Follow-up: Three-month review in nine weeks. Stop chlorthalidone and call if she cannot eat or drink normally. Next scheduled visit 1877-06-15: three-month review after chlorthalidone was stopped: blood pressure above target, losartan added; lipids on atorvastatin; knee and falls. [S]